deaths (OS)progression or deaths (PFS)RFS/DFS

endometrial cancer endometrial cancer

versus paclitaxel
pembrolizumab plus lenvatinib vs. paclitaxel 1 NaN [NaN; NaN] /10000
0/0 vs. 0/0
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-